Hyperliquid Strategies Inc and Sonnet BioTherapeutics Holdings, Inc. Announce Closing of Business Combination
Trading on The Nasdaq Capital Market under the ticker symbol “PURR”
| Date | Form | Description | XBRL | Pages | |
|---|---|---|---|---|---|
| 03/15/10 | 4 | Statement of changes in beneficial ownership of securities |
|
2 | |
| 03/10/10 | SC 13G | Schedule filed to report acquisition of beneficial ownership of 5% or more of a class of equity securities by passive investors and certain institutions |
|
4 | |
| 03/09/10 | 4 | Statement of changes in beneficial ownership of securities |
|
2 | |
| 03/09/10 | 5 | Annual statement of changes in beneficial ownership of securities |
|
2 | |
| 03/09/10 | 5 | Annual statement of changes in beneficial ownership of securities |
|
2 | |
| 02/25/10 | UPLOAD | SEC-generated letter |
|
1 | |
| 02/23/10 | 10-Q/A | Quarterly report pursuant to Section 13 or 15(d) |
|
29 | |
| 02/22/10 | 3 | Initial statement of beneficial ownership of securities |
|
1 | |
| 01/28/10 | 10-Q/A | Quarterly report pursuant to Section 13 or 15(d) |
|
28 | |
| 01/21/10 | 10-Q/A | Quarterly report pursuant to Section 13 or 15(d) |
|
27 |
